In patients with asthma, elevations of non-type-2 signals such as IL-6 correspond with higher blood neutrophil counts, obesity, a lower percent predicted FEV1, increased asthma-related hospitalizations, and increased use of systemic corticosteroids. Here, IL6 is linked to Obesity.